Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 09-2020 | 06-2020 | 03-2020 | 02-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 24 | N/A | -3 | -8 | -4 |
| Other Working Capital | 26 | -29 | 19 | 21 | -8 |
| Other Operating Activity | -136 | -36 | -33 | -338 | -9 |
| Operating Cash Flow | $-87 | $-65 | $-17 | $-325 | $-20 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -85 | -5 | 0 |
| Purchase Of Investment | N/A | N/A | N/A | -198 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-85 | $-203 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -3 | N/A |
| Common Stock Issued | N/A | N/A | 0 | 846 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 95 |
| Financing Cash Flow | $N/A | $N/A | $0 | $843 | $95 |
| Beginning Cash Position | 1,067 | 1,132 | 1,234 | 113 | 1,159 |
| End Cash Position | 981 | 1,067 | 1,132 | 427 | 1,234 |
| Net Cash Flow | $-87 | $-65 | $-102 | $314 | $75 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87 | -65 | -17 | -325 | -20 |
| Capital Expenditure | N/A | N/A | N/A | -5 | N/A |
| Free Cash Flow | -87 | -65 | -17 | -330 | -20 |